Genmab stock surges 11% on positive cancer drug trial data

🇩🇰 Investing.com (DK) — 2026-10-05

Genmab shares rose 11% after the company reported positive data from a cancer drug trial. The result links clinical research news with a substantial market reaction.

Markets Health Genmab cancer drug clinical trial positive trial data stock surge

Read original source →

Ogoni cleanup: Reps summon HYPREP over N400bn audit report
Punch Nigeria — 2026-10-05
Police pension fund weighs Dangote Refinery investment
Punch Nigeria — 2026-10-05
Germany Is Spending €2 Billion to Discover the Real Price of Clean Jet Fuel
Oilprice.com — 2026-10-05
Kwara rewards teachers with N120m, plans Dangote shares
Punch Nigeria — 2026-10-05
Evri acquires US-based Cross Border Connect
The Loadstar — 2026-10-05
NGX slips 0.06% as Nestlé, insurers drag market lower
Nairametrics Nigeria — 2026-10-05

Genmab stock surges 11% on positive cancer drug trial data

AI Summary

Related Articles

Ogoni cleanup: Reps summon HYPREP over N400bn audit report

Police pension fund weighs Dangote Refinery investment

Germany Is Spending €2 Billion to Discover the Real Price of Clean Jet Fuel

Kwara rewards teachers with N120m, plans Dangote shares

Evri acquires US-based Cross Border Connect

NGX slips 0.06% as Nestlé, insurers drag market lower